rs11657479
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_013351.2(TBX21):c.*169T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 906,968 control chromosomes in the GnomAD database, including 22,948 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_013351.2 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- asthma, nasal polyps, and aspirin intoleranceInheritance: AR Classification: LIMITED Submitted by: PanelApp Australia
- immunodeficiency 88Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_013351.2. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.198 AC: 30142AN: 152016Hom.: 3303 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.220 AC: 166399AN: 754832Hom.: 19649 Cov.: 10 AF XY: 0.220 AC XY: 83475AN XY: 379354 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.198 AC: 30143AN: 152136Hom.: 3299 Cov.: 32 AF XY: 0.197 AC XY: 14681AN XY: 74372 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at